| Literature DB >> 29045422 |
Kwang Hyun Kim1, Hyun Suk Yoon1, Wan Song1, Hee Jung Choo2, Hana Yoon1, Woo Sik Chung1, Bong Suk Sim1, Dong Hyeon Lee1.
Abstract
PURPOSE: To classify patients with orthotopic neobladder based on urodynamic parameters using cluster analysis and to characterize the voiding function of each group.Entities:
Mesh:
Year: 2017 PMID: 29045422 PMCID: PMC5646783 DOI: 10.1371/journal.pone.0185255
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1(A) Comparison of urodynamic parameters between the 3 groups. One-way ANOVA was used for statistical analysis. (B) Radar plot of urodynamic parameters among the 3 groups using standardized z-score.
Clinical and urinary functional outcomes of the 3 groups.
| Group 1 (n = 44) | Group 2 (n = 42) | Group 3 (n = 17) | P value | |
|---|---|---|---|---|
| Age (year), mean ± SD | 59.6±11.4 | 64.6±10.6 | 64.9±7.2 | 0.055 |
| Gender, n (%) | 0.003 | |||
| male | 41 (93.2) | 29 (69.0) | 10 (58.8) | |
| female | 3 (6.8) | 13 (31.0) | 7 (41.2) | |
| Postoperative period (month) | 0.628 | |||
| median, IQR | 6, 3–13 | 4, 3–10 | 5, 3–8.5 | |
| BMI (kg/m2), mean ± SD | 24.1±2.9 | 23.8±2.8 | 25.5±3.3 | 0.139 |
| Hypertension, n (%) | 16 (36.4) | 18 (42.9) | 8 (47.1) | 0.702 |
| Diabetes n (%) | 7 (15.9) | 7 (16.7) | 3 (17.6) | 0.986 |
| Daytime incontinence, n (%) | 5 (11.4) | 13 (31.0) | 7 (41.2) | 0.022 |
| Nightime incontinence, n (%) | 29 (65.9) | 35 (83.3) | 15 (88.2) | 0.076 |
| Vesicoureteral reflux, n (%) | 12 (27.3) | 23 (54.8) | 5 (29.4) | 0.022 |
| Febrile UTI, n (%) | 11 (25.0) | 11 (26.2) | 8 (47.1) | 0.203 |
SD = standard deviation, BMI = body mass index, UTI = urinary tract infection
Gender differences in urodynamic parameters and urinary functional outcomes.
| Male (n = 80) | Female (n = 23) | P value | |
|---|---|---|---|
| Urodyamic parameters, mean ± SD | |||
| Maximal bladder capacity (ml) | 462.3±110.7 | 423.9±155.4 | 0.186 |
| Residual urine volume (ml) | 74.8±130.6 | 140.3±180.9 | 0.116 |
| Maximal flow rate (ml/sec) | 14.3±8.8 | 15.0±11.0 | 0.738 |
| Compliance (ml/cmH2O) | 38.3±42.7 | 53.3±80.5 | 0.237 |
| Maximal abdominal pressure (cmH2O) | 126.5±44.0 | 108.7±36.1 | 0.080 |
| Urinary functional outcomes, n (%) | |||
| Daytime incontinence | 64 (80.0) | 14 (60.9) | 0.059 |
| Nighttime incontinence | 16 (20.0) | 9 (39.1) | 0.841 |
SD = standard deviation
Logistic regression analysis to predict factors associated with being assigned to group 1, the most ideal urodynamic pattern.
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Odd ratio | P value | Odd ratio | P value | |
| Age | 0.95 (0.91–0.99) | 0.02 | 0.95 (0.91–0.99) | 0.017 |
| Gender | ||||
| Female | Ref | Ref | ||
| Male | 7.00 (1.92–25.46) | 0.003 | 7.57 (2.03–28.19) | 0.003 |
| Hypertension | 0.72 (0.32–1.61) | 0.432 | ||
| Diabetes | 0.92 (0.32–2.66) | 0.888 | ||
| Body mass index | 0.98 (0.86–1.11) | 0.769 | ||
| Postoperative period (month) | 1.01 (0.98–1.03) | 0.394 | ||
Summary of previous studies which investigated the treatment of dysfunctional voiding in patients with orthotopic neobladder.
| Dysfunctional voiding | No. patients | Intervention | Result | |
|---|---|---|---|---|
| Ghoneim et al [ | Nocturnal incontinence | 32 | imipramine hydrochloride 25mg | improved in 8 patients (25%) |
| El-Bahnasawy et al [ | Nocturnal incontinence | 20 | oxybutinine | improved in 14 patients (70%) |
| El-Bahnasawy et al [ | Nocturnal incontinence | 20 | verapamil | improved in 11 patients (55%) |
| Goldberg et al [ | Nocturnal incontinence | 31 | desmopression 0.1mg | mean number of night time awakening decreased from 2.5/night to 1.5/night |
| Hoag et al [ | Overactive ileal neobladder | 4 | intravesical onabotulinumtoxinA | varying degrees of subjective improvements |